It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund

14/08/2015 - 2 minutes

Cash is floating into Biotech like never before, in the US as well as in Europe. And Woodford just announced he invested over 75% of the total money he raised, so over €800M. Let’s have a look at where the money went into.

Neil Woodford is a legendary British Biotech investor who opened a new mega €1.1Bn Biotech fund, named Woodford Patient Capital Trust, last April 2015. It is the biggest UK trust ever, outpassing the previous record of €750M (£549M) hold by Mercury European Privatisation.

Woodford didn’t wait to deploy the money, with already a lot of small and large investments within the 4 months after opening.

We covered several news here, as for example his investments in the Stem-cell therapy Biotech ReNeuron, in Oxford Sciences Innovation with Google Ventures, in PsiOxus, and of course in Immunocore’s monster €293M round (the second biggest worldwide after Moderna!!).

Woodford also made other investments:

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

You might also be interested in the following:

Support Us

Become a Member